By Kyle J. Norton
Beet, or beet root may have a therapeutic potential in inhibited onset of skin cancer, some scientists suggested.
Skin caner is a medical condition characterized by abnormal skin cell growth in disordered and uncontrollable ways.
Skin cancer is still a major cause of morbidity and mortality in US. According to statistic provided by Skin Cancer Foundation, approximately, 5.4 million cases of nonmelanoma skin cancer were treated in over 3.3 million people in the U.S, in 2012.
According to general belief, the major cause of skin cancer is accumulative sun exposure. However, most people do not know, accumulative sun exposure during the childhood also plays an important role in increased risk of skin cancer in adulthood.
Truly, occupation chemical exposure, aging and ethnicity are prevalent risk of skin cancer onset.
People with genetic or acquired genetic mutation gene such as NLRP1 may also associated to substantially increased risk of skin cancer(4).
The Singapore Institute of Molecular and Cellular Biology in joint study, wrote,”a group of non-fever inflammasome disorders, uncover an unexpected auto-inhibitory function for the pyrin domain, and provide the first genetic evidence linking NLRP1 to skin inflammatory syndromes and skin cancer predisposition”.
Beet with high amount of organic nitrate may have a profound effect on risk factor and treatment of skin cancer.
According to the Howard University, in the analysis of beet root, anti skin cancer effect in vivo, measurement from bioassays, beet root has a chemo preventive effect in expressed a significant inhibition on skin tumors of tested mice.
In skin tumor initiation by 390 nmol of 7,12-dimethylbenz(a)anthracene (DMBA) in 100 microl of acetone together with mouse skin tumor promotion with 3430 J/m(2) of ultraviolet light-B (UV-B), researchers found that administration of 0.0025% and topical application of 390 nmol of betanin, the major chemical constituent isolated from beet root, reveal a strong protection in the mouse skin cancer model.
Beside skin cancer, betanin, a regularly consumed natural product colorant found abundance in beet root may also be effective chemopreventive agent in treating other types of cancer , such as lung and liver cancers.
Other in the validated sugar beet pectin/gelatin hydrogels, in vivo, conjunction with anti cancer chemodrug, doxorubicin, demonstrated a successfully suppressed growth of a solid tumor created by applied to skin of mouse melanoma B16F1 cells into nude mice.
The findings reveal that beet, with high amounts of nitrate may be used as therapeutic and functional food in attenuated risk and treatment of skin cancer alone or combined with other chemoagents.
Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months
Back to Kyle J. Norton Home page http://kylejnorton.blogspot.ca
Kyle J. Norton(Scholar, Master of Nutrition), all right reserved.
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it’s news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada – Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.
(1) Chemoprevention of lung and skin cancer by Beta vulgaris (beet) root extract by Kapadia GJ1, Tokuda H, Konoshima T, Nishino H.(PubMed)
(2) Chemoprevention of DMBA-induced UV-B promoted, NOR-1-induced TPA promoted skincarcinogenesis, and DEN-induced phenobarbital promoted liver tumors in mice by extract of beetroot by Kapadia GJ1, Azuine MA, Sridhar R, Okuda Y, Tsuruta A, Ichiishi E, Mukainake T, Takasaki M, Konoshima T, Nishino H, Tokuda H.(PubMed)
(3) Injectable and biodegradable sugar beet pectin/gelatin hydrogels for biomedical applications by Takei T1, Sugihara K, Yoshida M, Kawakami K.(PubMed)
(4) Germline NLRP1 Mutations Cause Skin Inflammatory and Cancer Susceptibility Syndromes via Inflammasome Activation by Zhong FL1, Mamaï O2, Sborgi L3, Boussofara L4, Hopkins R5, Robinson K6, Szeverényi I6, Takeichi T7, Balaji R6, Lau A6, Tye H8, Roy K6, Bonnard C6, Ahl PJ5, Jones LA5, Baker PJ8, Lacina L6, Otsuka A9, Fournie PR10, Malecaze F10, Lane EB6, Akiyama M11, Kabashima K12, Connolly JE5, Masters SL8, Soler VJ10, Omar SS13, McGrath JA14, Nedelcu R15, Gribaa M16, Denguezli M4, Saad A16, Hiller S3, Reversade B(PubMed)